Skip to main content

4 Result(s)

within M. Lindsjö Remove this filter

and

  1. No Access

    Chapter

    New Drugs to Prevent Recurrence of Renal Stone Disease

    Many patients who are stone formers have recurrent stone formation, for which detailed clinical and biochemical work-up is necessary. Even if conventional treatments with thiazides, orthophosphate, or magnesiu...

    Bo G. Danielson, B. Fellström, M. Lindsjö, S. Ljunghall, B. Wikström in Nephrology (1991)

  2. No Access

    Chapter

    Intestinal Absorption of Oxalate and Calcium

    The majority of renal stones contain calcium oxalate (1, 2). In patients with idiopathic calcium stone disease, an increased excretion of both calcium and oxalate is reported (3, 4). After jejuno-ileal bypass ...

    M. Lindsjö, B. G. Danielson, B. Fellström, S. Ljunghall in Urolithiasis (1989)

  3. No Access

    Chapter and Conference Paper

    Clinical characteristics of renal stone disease in relation to urinary oxalate excretion

    The formation of calcium-containing renal stones is regarded as a multifactorial process involving high urinary concentrations of calcium and oxalate in combination with reduced excretion of inhibitory factors...

    M. Lindsjö, U. Backman, B. G. Danielson… in Pathogenese und Klinik der Harnsteine XIII (1988)

  4. No Access

    Chapter and Conference Paper

    The mechanism of glycosaminoglycan inhibition of calcium oxalate crystal growth

    Urinary inhibition of crystal growth and aggregation is an important determinant for stone formation in the urinary tract along with supersaturation of the urine (1). Naturally occurring inhibitors such as pyr...

    B. Fellström, B. G. Danielson, M. Lindsjö… in Pathogenese und Klinik der Harnsteine XI (1985)